Furthermore, treatment with an anti-CD244 monoclonal antibody significantly impaired the growth of established HNSCC tumors in wild-type mice and increased the infiltration of CD8+ T cells within the tumors (Agresta et al., 2020). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.